Retinal thickness as a potential biomarker in patients with amyloid‐proven early‐ and late‐onset Alzheimer's disease
Abstract Introduction Retinal thickness measured with optical coherence tomography has been proposed as a noninvasive biomarker for Alzheimer's disease (AD). We therefore measured retinal thickness in well‐characterized AD and control participants, considering ophthalmological confounders. Meth...
Main Authors: | Jurre denHaan, Jacoba A. van deKreeke, Elles Konijnenberg, Mara tenKate, Anouk denBraber, Frederik Barkhof, Bart N. vanBerckel, Charlotte E. Teunissen, Philip Scheltens, Pieter Jelle Visser, Frank D. Verbraak, Femke H. Bouwman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-12-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.dadm.2019.05.002 |
Similar Items
-
Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
by: Jurre denHaan, et al.
Published: (2019-12-01) -
Retinal thickness correlates with parietal cortical atrophy in early‐onset Alzheimer's disease and controls
by: Jurre denHaan, et al.
Published: (2018-01-01) -
Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study
by: Jacoba A. van de Kreeke, et al.
Published: (2020-04-01) -
White matter microstructure disruption in early stage amyloid pathology
by: Lyduine E. Collij, et al.
Published: (2021-01-01) -
Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study
by: Jori Tomassen, et al.
Published: (2022-01-01)